According to Goldman Sachs, GRANOLAS (Glaxosmithkline, Roche, ASML, Nestle, Novartis, Novo Nordisk, L’Oreal, LVMH, Astrazeneca, SAP and Sanofi) are expected to continue to outperform in the next market cycle, with their collective market cap representing 24% of the Europe’s Stoxx 600 index.

Image: Goldman Sachs Global Investment Research